Company Profiles

driven by the PitchBook Platform

Aminex Therapeutics

2008 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Series B LATEST DEAL TYPE (Cancelled)
$4.1M TOTAL AMOUNT RAISED
1 INVESTORS
Description

Developer of a small molecule immunotherapeutic product for cancer treatment. The company develops a product named Polyamine-Blocker Therapy (PaBT) that treats cancer by removing polyamines from cancer cells that is critical for their growth and metastasis.

Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Drug Discovery
Primary Office
11335 North East 122nd
Suite 105
Kenmore, WA 98028
United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Aminex Therapeutics’s full profile, request a free trial.

Aminex Therapeutics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Angel (individual) 12-Feb-2016 Cancelled Generating Revenue
2. Angel (individual) 01-Jun-2015 00.00 00.00 Completed Generating Revenue
1. Grant 10-Nov-2010 $244k Completed Startup
To view this company’s complete deal history including valuation and funding request access »

Aminex Therapeutics Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
United States Department of the Treasury Government 000 0000 000000 0

You’re viewing 1 of 1 investors.

Aminex Therapeutics Executive Team (3)

Name Title Board
Seat
Contact
Info
James Skaggs Chief Executive Officer & Chairman
Mark Burns Ph.D Chief Scientific Officer, Board Member, President and Scientific Founder
Thomas Graham Chief Operating Officer & Board Member

You’re viewing 3 of 3 executives.

Aminex Therapeutics Board Members (7)

Name Representing Role Since Contact
Info
Donald Mowat Self Board Member 000 0000
Jack Rosling Self Board Member 000 0000
James Skaggs Aminex Therapeutics Chief Executive Officer & Chairman 000 0000
Jeffrey Miller Ph.D Aminex Therapeutics Board Member 000 0000
John Rostling Self Board Member 000 0000
You’re viewing 5 of 7 board members. Get the full list »